{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:48:41Z","timestamp":1788281321774,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020MH316"],"award-info":[{"award-number":["ZR2020MH316"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020QH089"],"award-info":[{"award-number":["ZR2020QH089"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2016HM52"],"award-info":[{"award-number":["ZR2016HM52"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>To explore the associations between hormones, metabolic markers, and low bone mass in perimenopausal and postmenopausal women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>A total of 198 women were enrolled in this study. The correlations between hormones, metabolic markers, and BMD were analyzed. Risk factors for bone loss were identified. Receiver operating characteristic (ROC) curves were used to display the predictive power of these risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The years since menopause and the levels of glucose (GLU), follicle-stimulating hormone (FSH), and luteinizing hormone (LH) were inversely correlated with BMD, while estrogen and testosterone were positively correlated with BMD. Age (odds ratio [OR] 1.232; 95% confidence interval [CI] 1.106\u20131.372;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), GLU (OR 1.848; 95% CI 1.116\u20133.059;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.017), and FSH (OR 1.089; 95% CI 1.003\u20131.182;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.042) were identified as risk factors for bone loss. Age (AUC\u2009=\u20090.884, 95% CI 0.833\u20130.935), FSH (AUC\u2009=\u20090.824, 95% CI 0.760\u20130.888), and GLU (AUC\u2009=\u20090.683, 95% CI 0.599\u20130.768) demonstrated significant discrimination capability for bone loss. The combined application of these factors resulted in a better prediction effect (AUC\u2009=\u20090.930, 95% CI 0.893\u20130.967).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Age, FSH, and GLU were found to be specific risk factors for bone loss. The utilization of these factors offers compelling predictive power for bone loss in perimenopausal and postmenopausal women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00774-025-01595-x","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T12:41:38Z","timestamp":1741178498000},"page":"392-401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Associations between hormones, metabolic markers, and bone mass in perimenopausal and postmenopausal women"],"prefix":"10.1007","volume":"43","author":[{"given":"Bingru","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunxiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guolin","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2844-2770","authenticated-orcid":false,"given":"Yiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"1595_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ecl.2021.03.009","volume":"50","author":"RM Arceo-Mendoza","year":"2021","unstructured":"Arceo-Mendoza RM, Camacho PM (2021) Postmenopausal osteoporosis: latest guidelines. Endocrinol Metab Clin North Am 50:167\u2013178","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1595_CR2","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1210\/en.2018-00601","volume":"159","author":"M Zaidi","year":"2018","unstructured":"Zaidi M, Lizneva D, Kim SM, Sun L, Iqbal J et al (2018) FSH, bone mass, body fat, and biological aging. Endocrinology 159:3503\u20133514","journal-title":"Endocrinology"},{"key":"1595_CR3","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1530\/JOE-16-0405","volume":"232","author":"A Krishnan","year":"2017","unstructured":"Krishnan A, Muthusami S (2017) Hormonal alterations in PCOS and its influence on bone metabolism. J Endocrinol 232:R99\u2013R113","journal-title":"J Endocrinol"},{"key":"1595_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fendo.2020.00122","volume":"11","author":"C Cipriani","year":"2020","unstructured":"Cipriani C, Colangelo L, Santori R, Renella M, Mastrantonio M et al (2020) The interplay between bone and glucose metabolism. Front Endocrinol (Lausanne) 11:122","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1595_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1152\/physrev.00033.2015","volume":"97","author":"M Almeida","year":"2017","unstructured":"Almeida M, Laurent MR, Dubois V, Claessens F, O\u2019Brien CA et al (2017) Estrogens and androgens in skeletal physiology and pathophysiology. Physiol Rev 97:135\u2013187","journal-title":"Physiol Rev"},{"key":"1595_CR6","doi-asserted-by":"crossref","unstructured":"Khosla S, Monroe DG (2018) Regulation of bone metabolism by sex steroids. Cold Spring Harb Perspect Med 8(1):a031211","DOI":"10.1101\/cshperspect.a031211"},{"key":"1595_CR7","first-page":"1017","volume":"19","author":"U Foger-Samwald","year":"2020","unstructured":"Foger-Samwald U, Dovjak P, Azizi-Semrad U, Kerschan-Schindl K, Pietschmann P (2020) Osteoporosis: pathophysiology and therapeutic options. EXCLI J 19:1017\u20131037","journal-title":"EXCLI J"},{"key":"1595_CR8","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1177\/0192623317735316","volume":"45","author":"MN Weitzmann","year":"2017","unstructured":"Weitzmann MN (2017) Bone and the immune system. Toxicol Pathol 45:911\u2013924","journal-title":"Toxicol Pathol"},{"key":"1595_CR9","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1007\/s00198-019-05103-6","volume":"30","author":"P Hadji","year":"2019","unstructured":"Hadji P, Colli E, Regidor PA (2019) Bone health in estrogen-free contraception. Osteoporos Int 30:2391\u20132400","journal-title":"Osteoporos Int"},{"key":"1595_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00198-002-1307-x","volume":"14","author":"MR Sowers","year":"2003","unstructured":"Sowers MR, Finkelstein JS, Ettinger B, Bondarenko I, Neer RM et al (2003) The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN. Osteoporos Int 14:44\u201352","journal-title":"Osteoporos Int"},{"key":"1595_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/ncprheum0070","volume":"2","author":"CJ Rosen","year":"2006","unstructured":"Rosen CJ, Bouxsein ML (2006) Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2:35\u201343","journal-title":"Nat Clin Pract Rheumatol"},{"key":"1595_CR12","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1210\/jc.2006-0572","volume":"92","author":"LJ Zhao","year":"2007","unstructured":"Zhao LJ, Liu YJ, Liu PY, Hamilton J, Recker RR, Deng HW (2007) Relationship of obesity with osteoporosis. J Clin Endocrinol Metab 92:1640\u20131646","journal-title":"J Clin Endocrinol Metab"},{"key":"1595_CR13","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1186\/s12891-021-04643-5","volume":"22","author":"B Kan","year":"2021","unstructured":"Kan B, Zhao Q, Wang L, Xue S, Cai H, Yang S (2021) Association between lipid biomarkers and osteoporosis: a cross-sectional study. BMC Musculoskelet Disord 22:759","journal-title":"BMC Musculoskelet Disord"},{"key":"1595_CR14","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJMcp2307353","volume":"389","author":"MD Walker","year":"2023","unstructured":"Walker MD, Shane E (2023) Postmenopausal osteoporosis. N Engl J Med 389:1979\u20131991","journal-title":"N Engl J Med"},{"key":"1595_CR15","doi-asserted-by":"publisher","first-page":"16568","DOI":"10.1073\/pnas.1308755110","volume":"110","author":"Y Miyauchi","year":"2013","unstructured":"Miyauchi Y, Sato Y, Kobayashi T, Yoshida S, Mori T et al (2013) HIF1alpha is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis. Proc Natl Acad Sci U S A 110:16568\u201316573","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1595_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2019.100225","volume":"11","author":"NS Soysa","year":"2019","unstructured":"Soysa NS, Alles N (2019) Positive and negative regulators of osteoclast apoptosis. Bone Rep 11:100225","journal-title":"Bone Rep"},{"key":"1595_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/MED.0b013e328339658c","volume":"17","author":"PR Ebeling","year":"2010","unstructured":"Ebeling PR (2010) Androgens and osteoporosis. Curr Opin Endocrinol Diabetes Obes 17:284\u2013292","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1595_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbrc.2010.02.113","volume":"394","author":"L Sun","year":"2010","unstructured":"Sun L, Zhang Z, Zhu LL, Peng Y, Liu X et al (2010) Further evidence for direct pro-resorptive actions of FSH. Biochem Biophys Res Commun 394:6\u201311","journal-title":"Biochem Biophys Res Commun"},{"key":"1595_CR19","doi-asserted-by":"publisher","unstructured":"Gera S, Kuo TC, Gumerova AA, Korkmaz F, Sant D, DeMambro V, et al (2022) FSH-blocking therapeutic for osteoporosis. Elife. https:\/\/doi.org\/10.7554\/eLife.78022","DOI":"10.7554\/eLife.78022"},{"key":"1595_CR20","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1007\/s00198-010-1505-x","volume":"22","author":"ML Gourlay","year":"2011","unstructured":"Gourlay ML, Preisser JS, Hammett-Stabler CA, Renner JB, Rubin J (2011) Follicle-stimulating hormone and bioavailable estradiol are less important than weight and race in determining bone density in younger postmenopausal women. Osteoporos Int 22:2699\u20132708","journal-title":"Osteoporos Int"},{"key":"1595_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.bone.2011.11.001","volume":"50","author":"ML Gourlay","year":"2012","unstructured":"Gourlay ML, Specker BL, Li C, Hammett-Stabler CA, Renner JB, Rubin JE (2012) Follicle-stimulating hormone is independently associated with lean mass but not BMD in younger postmenopausal women. Bone 50:311\u2013316","journal-title":"Bone"},{"key":"1595_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1210\/edrv.23.3.0465","volume":"23","author":"BL Riggs","year":"2002","unstructured":"Riggs BL, Khosla S, Melton LJ 3rd (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279\u2013302","journal-title":"Endocr Rev"},{"key":"1595_CR23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1055\/s-2007-984740","volume":"25","author":"JE Hall","year":"2007","unstructured":"Hall JE (2007) Neuroendocrine changes with reproductive aging in women. Semin Reprod Med 25:344\u2013351","journal-title":"Semin Reprod Med"},{"key":"1595_CR24","doi-asserted-by":"crossref","unstructured":"Kupai K, Kang HL, Posa A, Csonka A, Varkonyi T, Valkusz Z (2024) Bone loss in diabetes mellitus: diaporosis. Int J Mol Sci 25:7269","DOI":"10.3390\/ijms25137269"},{"key":"1595_CR25","doi-asserted-by":"publisher","first-page":"706","DOI":"10.4239\/wjd.v12.i6.706","volume":"12","author":"R Palui","year":"2021","unstructured":"Palui R, Pramanik S, Mondal S, Ray S (2021) Critical review of bone health, fracture risk and management of bone fragility in diabetes mellitus. World J Diabetes 12:706\u2013729","journal-title":"World J Diabetes"},{"key":"1595_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S8756-3282(97)00220-2","volume":"22","author":"M Terada","year":"1998","unstructured":"Terada M, Inaba M, Yano Y, Hasuma T, Nishizawa Y et al (1998) Growth-inhibitory effect of a high glucose concentration on osteoblast-like cells. Bone 22:17\u201323","journal-title":"Bone"},{"key":"1595_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s005920170007","volume":"38","author":"AD McCarthy","year":"2001","unstructured":"McCarthy AD, Etcheverry SB, Cortizo AM (2001) Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development. Acta Diabetol 38:113\u2013122","journal-title":"Acta Diabetol"},{"key":"1595_CR28","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/stem.1659","volume":"32","author":"EC Keats","year":"2014","unstructured":"Keats EC, Dominguez JM 2nd, Grant MB, Khan ZA (2014) Switch from canonical to noncanonical Wnt signaling mediates high glucose-induced adipogenesis. Stem Cells 32:1649\u20131660","journal-title":"Stem Cells"},{"key":"1595_CR29","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1210\/jc.2012-3634","volume":"98","author":"PK Fazeli","year":"2013","unstructured":"Fazeli PK, Horowitz MC, MacDougald OA, Scheller EL, Rodeheffer MS et al (2013) Marrow fat and bone\u2013new perspectives. J Clin Endocrinol Metab 98:935\u2013945","journal-title":"J Clin Endocrinol Metab"},{"key":"1595_CR30","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/jcp.22291","volume":"225","author":"LF Liu","year":"2010","unstructured":"Liu LF, Shen WJ, Zhang ZH, Wang LJ, Kraemer FB (2010) Adipocytes decrease Runx2 expression in osteoblastic cells: roles of PPARgamma and adiponectin. J Cell Physiol 225:837\u2013845","journal-title":"J Cell Physiol"},{"key":"1595_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bbrc.2015.02.091","volume":"461","author":"K Tanaka","year":"2015","unstructured":"Tanaka K, Yamaguchi T, Kanazawa I, Sugimoto T (2015) Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells. Biochem Biophys Res Commun 461:193\u2013199","journal-title":"Biochem Biophys Res Commun"},{"key":"1595_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF03343726","volume":"23","author":"SA Kemink","year":"2000","unstructured":"Kemink SA, Hermus AR, Swinkels LM, Lutterman JA, Smals AG (2000) Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J Endocrinol Invest 23:295\u2013303","journal-title":"J Endocrinol Invest"},{"key":"1595_CR33","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.2337\/diacare.28.12.2850","volume":"28","author":"J Miao","year":"2005","unstructured":"Miao J, Brismar K, Nyren O, Ugarph-Morawski A, Ye W (2005) Elevated hip fracture risk in type 1 diabetic patients: a population-based cohort study in Sweden. Diabetes Care 28:2850\u20132855","journal-title":"Diabetes Care"},{"key":"1595_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115690","volume":"142","author":"SK Park","year":"2021","unstructured":"Park SK, Jung JY, Oh CM, Choi JM, Kim MH et al (2021) Fasting glucose level and the risk of incident osteoporosis in the Koreans. Bone 142:115690","journal-title":"Bone"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-025-01595-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-025-01595-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-025-01595-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T06:55:50Z","timestamp":1757141750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-025-01595-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1595"],"URL":"https:\/\/doi.org\/10.1007\/s00774-025-01595-x","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All other authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Shandong Provincial Hospital Affiliated to Shandong First Medical University. Written informed consent was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}